Journal
Journal of experimental medicine
Publication Date
2-2-2026
Volume
223
Issue
2
First Page
e20251860
Document Type
Open Access Publication
DOI
10.1084/jem.20251860
Rights and Permissions
Leon C.D. Smyth, Daan Verhaege, Elio Standen-Bloom, Yue Wu, Yiming Gan, Steffen E. Storck, Pavle Boskovic, Benjamin A. Plog, Tornike Mamuladze, Jose A. Mazzitelli, Zhuoying Wang, Daniel D. Lee, Gwendalyn J. Randolph, Antoine Drieu, Katherine E. Schwetye, Song Hu, Daniel S. Reich, Douglas H. Kelley, Rupal I. Mehta, Jonathan Kipnis; Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease. J Exp Med 2 February 2026; 223 (2): e20251860. © 2025 Smyth et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20251860.
Recommended Citation
Smyth, Leon C D; Verhaege, Daan; Standen-Bloom, Elio; Wu, Yue; Storck, Steffen E; Boskovic, Pavle; Plog, Benjamin A; Mamuladze, Tornike; Mazzitelli, Jose A; Wang, Zhuoying; Lee, Daniel D; Randolph, Gwendalyn J; Schwetye, Katherine E; Hu, Song; Kipnis, Jonathan; and et al., "Amyloidosis of bridging veins is a pathologic feature of Alzheimer's disease." Journal of experimental medicine. 223, 2. e20251860 (2026).
https://digitalcommons.wustl.edu/oa_4/6049
Department
ICTS (Institute of Clinical and Translational Sciences)
Table S1: Antibodies and stains
jem_20251860_tables2.docx (15 kB)
Table S2: Human subjects
